Use the Search Fields to Find Information
Page 8 of 356
Use of Cannabis for Harm Reduction Among People at High Risk for Overdose in Vancouver, Canada (2016–2018)
Please use this link to access this publication. Abstract Objectives. To characterize the prevalence and reasons for the use of cannabis as a strategy to reduce
July 18, 2025
Use of Cannabis as a Harm Reduction Strategy Among People Who Use Drugs: A Cohort Study
Please use this link to access this publication: https://www.liebertpub.com/doi/full/10.1089/can.2021.0229 Abstract Introduction: While substance use contributes to a substantial burden of disease, access to evidence-based harm reduction interventions
November 29, 2023
Use of Cannabis and Cannabinoids in Patients With Cancer
Please use this link to access this publication. Abstract Objective: To review pharmacology, available dosage forms, efficacy, and safety of cannabis and cannabinoids in cancer
October 3, 2024
Use of Cannabis and Cannabinoids for Treatment of Cancer
Abstract The endocannabinoid system (ECS) is an ancient homeostasis mechanism operating from embryonic stages to adulthood. It controls the growth and development of many cells
February 29, 2024
Use of cannabinoids in cancer care: palliative care
All too often neglected, maximal quality improvement in the setting of life-limiting illness and noxious symptomatology is a worthy medical, public health, and humanitarian goal.
August 16, 2022
Use of cannabinoids for the treatment of patients with post-traumatic stress disorder
Abstract Objectives: Post-traumatic Stress Disorder (PTSD) is a diagnosis of extreme anxiety caused by a traumatic event. Less than 10% of individuals who have experienced
August 15, 2023
Use of cannabidiol in the treatment of epilepsy
ABSTRACT Introduction. Cannabis sativa has been cultivated for human use for about 5,000 years, and has likewise been used in the treatment of epilepsy for
March 21, 2024
Use of Cannabidiol in the Management of Insomnia: A Systematic Review
Please use this link to access this publication. Abstract Background: Cannabidiol (CBD), one of the major cannabinoids derived from the cannabis plant, is available over the
December 17, 2024
Use of cannabidiol in anxiety and anxiety-related disorders
Please use this link to access this publication. Abstract Objective Cannabidiol (CBD) has a proposed novel role in the management of anxiety owing to its
July 2, 2024
Page 8 of 356